NCT07063147 TTE Improves Clinical Management of Stable Chest Pain
| NCT ID | NCT07063147 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tianjin Chest Hospital |
| Condition | Transthorcic Echocardiography |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2025-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.
Eligibility Criteria
Inclusion Criteria: * symptomatic patients with SCP suspected of obstructive CAD. * referred for TTE for the assessment of SCP. * ≥18 years of age. * signed informed consent. Exclusion Criteria: * acute coronary syndromes * previous CAD or coronary revascularization * nonsinus rhythm * cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07063147 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Transthorcic Echocardiography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07063147 currently recruiting?
Yes, NCT07063147 is actively recruiting participants. Contact the research team at zhoujiawenzhang@126.com for enrollment information.
Where is the NCT07063147 trial being conducted?
This trial is being conducted at Tianjin, China.
Who is sponsoring the NCT07063147 clinical trial?
NCT07063147 is sponsored by Tianjin Chest Hospital. The trial plans to enroll 50,000 participants.